| Description |
1 online resource (x, 431 pages) : illustrations |
| Series |
Methods in pharmacology and toxicology |
|
Methods in pharmacology and toxicology.
|
| Contents |
Cardiac Drug Development Guide -- Preface -- Contents -- Contributors -- I INTRODUCTION -- 1 Cardiac Drug Development: From Animal Models to Clinical Trials -- II Novel Molecular Targets for Cardiac Drug Development -- 2 The Role of Cardiac Pacemaker Currents in Antiarrhythmic Drug Discovery -- 3 Oxygen Free Radicals in Heart Disease: Novel Therapies -- 4 Mitogen-Activated Protein Kinases-Mediated Signaling in Cardiac Pathology: A Perspective of Novel Therapeutic Targets? -- 5 Development of Anti-Inflammatory Drugs for Cardiovascular Disease |
|
6 Development and Use of Platelet Glycoprotein Antagonists in Heart Disease -- 7 The Sodium-Hydrogen Exchange System in the Heart: A Target for the Protection of the Ischemic and Reperfused Heart and Inhibition of Heart Failure -- 8 Nitric Oxide and Cardiac Ischemia -- III FUNCTIONAL ENDPOINTS EVALUATING CARDIAC DRUG ACTIVITY -- 9 Ionic Mechanisms of Atrial Fibrillation -- 10 Targeting Ischemic Ventricular Arrhythmias -- 11 Biochemical Mediators of Ventricular Arrhythmias in Ischemic Heart Disease -- 12 Heterologous Expression Systems and Screening Technologies in Ion Channel Drug Discovery |
|
13 Molecular Diversity of Ion Channels in the Mouse Heart: A Suitable Model for Cardiac Drug Development? -- 14 Delayed Protection of the Myocardium: A Novel Therapeutic Window for Cardiac Drug Development -- IV CLINICAL ASPECTS IN CARDIAC DRUG DEVELOPMENT -- 15 Cardiac Troponin Testing for Detection of Myocardial Infarction: Clinical Utility and Analytical Issues -- 16 A Genetic Basis for Cardiac Arrhythmias: Current Status and the Future -- 17 Myocardial Adenoviral Vector Delivery for Cardiovascular Gene Therapy -- 18 The Role of Pharmacometrics in Cardiovascular Drug Development |
|
19 Gender Differences in Heart Failure: Concerns for Drug Development -- 20 Angiogenesis Therapies for Coronary Artery Disease: Trials and Tribulations -- Index |
| Summary |
The revolution in molecular medicine makes it imperative to integrate the classical and molecular approaches to drug development for the treatment of heart disease, the number one killer in North America and Europe. In the Cardiac Drug Development Guide, basic medical researchers, clinicians, and pharmacologists join forces to comprehensively survey the most recent breakthroughs in molecular cardiology and review the latest drug discoveries in cardiac and cardiovascular medicine. Topics range from novel molecular targets for cardiac drug development, to functional endpoints for evaluating cardiac drug activity, to clinical aspects of cardiovascular therapeutics. The authors describe the most advanced procedures in cardiovascular pharmacology, including in vivo and in vitro whole animal studies, the electrophysiological methods used to study pacemaker cells, and the application of biochemical principles and technologies to novel therapeutic agents. Also discussed are the methods used to express the ion channels involved in cardiovascular pharmacology, adenoviral vector delivery for cardiovascular gene therapy, pharmacometrics in cardiovascular drug development, gender differences in heart failure, and angiogenesis therapies for coronary heart disease. Each chapter concisely illustrates the concepts described and includes comprehensive background information, detailed figures and tables, and an up-to-date list of the most important references. Comprehensive and easy-to-understand, the Cardiac Drug Development Guide offers pharmacologists, cardiologists, and physiologists not only a gold-standard survey of the many different methods being used to develop new heart drugs, but also details powerful new ways in which cardiovascular disease is targeted, from the whole organ to the genetic level |
| Bibliography |
Includes bibliographical references and index |
| Notes |
English |
|
Print version record |
| Subject |
Cardiovascular agents.
|
|
Drug development.
|
|
Drugs -- Design.
|
|
Cardiovascular Agents -- pharmacology
|
|
Drug Design
|
|
Drug Evaluation, Preclinical -- methods
|
|
Cardiovascular Agents
|
|
MEDICAL -- Pharmacology.
|
|
Drugs -- Design
|
|
Cardiovascular agents
|
|
Drug development
|
| Genre/Form |
Laboratory manuals.
|
|
Manuels de laboratoire.
|
| Form |
Electronic book
|
| Author |
Pugsley, Michael K.
|
| ISBN |
1588290972 |
|
9781588290977 |
|
1592594042 |
|
9781592594047 |
|
1280842776 |
|
9781280842771 |
|
9786610842773 |
|
6610842779 |
|
